Twist Bioscience (TWST) | Stock Overview & Key Data

What is TWST's 52-week high and low?

In the last 52 weeks, Twist Bioscience reached a high of $60.90 (on July 26, 2024) and a low of $27.12 (on May 23, 2025).

What is the market cap and P/E ratio for TWST?

Curious about Twist Bioscience's size and valuation? Its market capitalization stands at 2.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is -9.85, and the forward P/E (looking ahead) is -14.78.

Does TWST pay dividends? If so, what's the yield?

As for dividends, Twist Bioscience isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Twist Bioscience's main competitors or similar companies to consider before investing?

When looking at Twist Bioscience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Thermo Fisher TMO	152.45B	Healthcare	Diagnostics & Research	-20.51%	-22.46%
Danaher DHR	140.51B	Healthcare	Diagnostics & Research	-15.07%	-13.10%
Grail GRAL	1.51B	Healthcare	Diagnostics & Research	207.37%	219.56%
Opko Health OPK	1.01B	Healthcare	Diagnostics & Research	7.94%	-51.60%
Neogen NEOG	1.04B	Healthcare	Diagnostics & Research	-65.00%	-77.21%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Twist Bioscience Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Twist Bioscience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -38.22%, the Debt to Equity ratio from the most recent quarter is 18.25, and its Gross Profit Margin stands at 49.60%.

What is the recent revenue and earnings growth for TWST?

Looking at Twist Bioscience's growth, its revenue over the trailing twelve months (TTM) was $348M. Compared to the same quarter last year (YoY), quarterly revenue grew by 23.20%, and quarterly earnings saw a YoY growth of 23.23%.

How much of TWST stock is held by insiders and institutions?

Wondering who owns Twist Bioscience stock? Company insiders (like executives and directors) hold about 1.98% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 115.00%.

For more common questions about our data, please visit our About Data page.